Status:
COMPLETED
Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers
Lead Sponsor:
Allergan
Conditions:
Acute Bacterial Corneal Ulcers
Bacterial Keratitis
Eligibility:
All Genders
8+ years
Phase:
PHASE2
Brief Summary
This study evaluates the safety and efficacy of gatifloxacin 0.3% ophthalmic solution compared with ciprofloxacin 0.3% ophthalmic solution in patients with acute bacterial corneal ulcers
Eligibility Criteria
Inclusion
- Clinical diagnosis in one eye only of an acute bacterial corneal ulcer (\>1mm)
Exclusion
- Corneal ulcer that in the opinion of the investigator had to be treated with fortified antibiotics, or multiple antibiotics, or anti-infectives other than study medication
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT00651586
Start Date
October 1 2003
End Date
April 1 2005
Last Update
July 29 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Galveston, Texas, United States
2
Madurai, Tamil Nadu, India